| Bioactivity | Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities[1][2]. |
| Name | Cevidoplenib dimesylate |
| CAS | 2043659-93-2 |
| Formula | C27H35N7O9S2 |
| Molar Mass | 665.74 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 31, No. 4, 2017. [2]. cevidoplenib dimesylate. |
Cevidoplenib dimesylate
CAS: 2043659-93-2 F: C27H35N7O9S2 W: 665.74
Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.